Matthew Blanchard, MD
Interventional Pain Medicine · Gulfport, MSNPI 1043741705
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Abbott at 27.2% of the total. Reporting peaked in 2022 at $4,372 and has fallen 61.5% since, to $1,682 in 2025.
Across 139 payments — averaging $75.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Boston Scientific$2K
- Medtronic$2K
- Pacira Pharmaceuticals Incorporated$1K
- Relievant Medsystems, Inc.$1K
- Curonix LLC$458
- plus $690 from 10 others
What the payments were for
- Travel & lodging$5,40752%
- Food & beverage$5,07448%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 28 | $2,850 |
| Boston Scientific | 22 | $2,351 |
| Medtronic | 16 | $1,645 |
| Pacira Pharmaceuticals Incorporated | 9 | $1,270 |
| Relievant Medsystems, Inc. | 12 | $1,218 |
| Curonix LLC | 17 | $458 |
| Spinal Simplicity, LLC | 15 | $222 |
| Biotronik NRO, Inc. | 5 | $160 |
| Nalu Medical, Inc. | 5 | $87 |
| SPR Therapeutics, Inc | 2 | $71 |
| MML US, Inc. | 2 | $47 |
| Merck | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Vertos Medical, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $18 |
| Avanos Medical | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,482 in reported general payments places this provider in the 85th percentile of 24 interventional pain medicine providers in Mississippi.
See all interventional pain medicine providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 595 | $18,115 |
| Buprenorphine | 18 | $4,553 |
| Pregabalin | 175 | $4,547 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 107 | $3,211 |
| Gabapentin | 146 | $2,128 |
| Lidocaine | 15 | $1,674 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 62 | $1,220 |
| Tizanidine Hcl | 84 | $992 |
| Tramadol Hcl | 102 | $802 |
| Methocarbamol | 47 | $796 |
| Celecoxib | 29 | $716 |
| Cyclobenzaprine Hcl | 76 | $648 |
| Duloxetine Hcl | 48 | $521 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $265 |
| Baclofen | 20 | $219 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Gulfport
- Shawn WuGulfport$1K
- Ramakrishna SettipalliGulfport$662
- Shawn MeiGulfport$202
- Leonel VanceMadison$21K
- Eric PearsonMeridian$19K
- Charles MartinMeridian$18K
- Kenneth StaggsMeridian$5K
- Madelyn CraigMadison$5K
- John LutzJackson$5K
- Michael SteuerSouthaven$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.